Investors

A lab technician marks a test tube in a lab
  • Creating value for our company, our shareholders and society

Investors

We aim for sustainable performance over time to benefit patients, employees, shareholders and society. Solid financial results and maintaining the trust of society underpin our ability to create value.

Novartis Campus Entrance

Novartis Investors Event Calendar

View recent presentations and learn more about upcoming events.

Zolgensma US FDA Approval
May 27, 2019

Learn More

Alcon brochure cover

Spin-off of Alcon

Read the media release

Download the Swiss Listing Prospectus (PDF 2.2 MB)

Download the Supplement to the Swiss Listing Prospectus (PDF 0.4 MB)

Download the Alcon 20-F (PDF 2.0 MB)

Download the Form 6-K: Alcon Appoints Senior Leaders in Final Preparation for Spin-off (PDF 0.1 MB)

Download the Form 8937: Basis of Securities (PDF 0.1 MB)

  • Share Data & Analysis

    Find information on Novartis share performance and dividend payouts.

    Learn More

  • Financial Data

    Review and download annual and quarterly reports, SEC filings and product sales information.

    Learn More

  • Shareholder Information

    Find information for shareholders and learn about our Annual General Meeting.

    Learn More

  • Company Overview

    Learn about Novartis leaders, corporate governance, our clinical pipeline and more.

    Learn More

Share Price

  • SIX

    87.25CHF

    as of May 24, 17:30 CEST

    +2.55 (+3.01%)

  • NYSE

    87.52USD

    as of May 24, 16:02 EDT

    +3.08 (+3.65%)

View stock performance
Featured Publications and Recent News
A pipette drops into test tubes

Novartis Clinical Pipeline

Our broad portfolio and strong pipeline help us offset the recurring impact of patent expirations for key products.

Explore Our Pipeline

Investor Relations Contacts

For questions about investor relations or the share registry, please contact our team.